Milestone Pharmaceuticals, Inc. (MIST)
0.8097
-0.01
(-0.74%)
USD |
NASDAQ |
Oct 02, 16:00
0.8036
-0.01
(-0.75%)
After-Hours: 20:00
Milestone Pharmaceuticals Net Income (Quarterly) : -28.61M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.61M |
| March 31, 2026 | -26.07M |
| December 31, 2025 | -17.41M |
| September 30, 2025 | -11.92M |
| June 30, 2025 | -12.97M |
| March 31, 2025 | -20.76M |
| December 31, 2024 | -12.36M |
| September 30, 2024 | -9.439M |
| June 30, 2024 | -9.363M |
| March 31, 2024 | -10.35M |
| December 31, 2023 | -13.61M |
| September 30, 2023 | -15.08M |
| June 30, 2023 | -16.04M |
| March 31, 2023 | -14.95M |
| December 31, 2022 | -13.18M |
| Date | Value |
|---|---|
| September 30, 2022 | -14.56M |
| June 30, 2022 | -16.65M |
| March 31, 2022 | -14.01M |
| December 31, 2021 | -16.88M |
| September 30, 2021 | -14.22M |
| June 30, 2021 | 0.77M |
| March 31, 2021 | -12.51M |
| December 31, 2020 | -8.666M |
| September 30, 2020 | -11.98M |
| June 30, 2020 | -12.98M |
| March 31, 2020 | -16.34M |
| December 31, 2019 | -18.29M |
| September 30, 2019 | -12.83M |
| June 30, 2019 | -13.66M |
| March 31, 2019 | -10.45M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -4.843M |
| NervGen Pharma Corp. | -21.10M |
| Clearmind Medicine, Inc. | -0.9073M |
| Lexaria Bioscience Corp. | -1.993M |
| Target Group, Inc. (Canada) | -0.2398M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.559M |
| Total Expenses (Quarterly) | 29.17M |
| EPS Diluted (Quarterly) | -0.2063 |
| Enterprise Value | 72.03M |
| Gross Profit Margin (Quarterly) | 84.08% |
| Profit Margin (Quarterly) | -5.12K% |
| Earnings Yield | -85.69% |
| Normalized Earnings Yield | -85.69 |